Sarepta Therapeutics is a biopharmaceutical company based in Cambridge, Massachusetts, that focuses on treatments for rare neuromuscular diseases. Its main work centres on therapies for Duchenne muscular dystrophy, including exon-skipping medicines and a gene therapy designed to deliver a working version of the dystrophin gene. The company also develops treatments for other rare muscle and central nervous system conditions. Its customers are mainly patients, clinicians and healthcare systems that treat people with these serious genetic disorders.
Sarepta Therapeutics Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code S1RP34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1087 of 1454 on the Sao Paulo Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Brazil yet.
TrendWeak
46/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-2.3%
From 52-week high-26.0%
MomentumWeak
44/100
Lagging most stocks on this exchange.
See the numbers →
3-month return16.4%
6-month return-8.3%
12-month, skipping last month-15.7%
Stability (higher is calmer)Weak
23/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)78.0%
Worst drawdown, 1 year (smaller is calmer)-41.6%
LiquidityWeak
38/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.01M BRL
Zero-volume days8.3%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Brazil when fundamentals data for this market is added. All Brazil stocks.
52-wk range 3.750 – 6.650Daily closes, split-adjusted
Signals
50-day average4.971
200-day average4.861
Golden/death cross (60d)Golden, 7 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.190
Technical summary
Daily
Neutral
6 bullish · 2 neutral · 8 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
4.41
Bullish
EMA 10
4.49
Bullish
SMA 20
4.60
Bullish
EMA 20
4.61
Bullish
SMA 50
4.97
Bearish
EMA 50
4.76
Bearish
SMA 100
4.66
Bullish
EMA 100
4.80
Bearish
SMA 200
4.86
Bearish
EMA 200
5.56
Bearish
Oscillators (daily)
RSI (14)
51.67
Neutral
MACD (12, 26)
-0.16
Bearish
Momentum (12)
3.26
Bullish
Stochastic %K (14)
91.04
Bearish
Williams %R (14)
-8.96
Bearish
CCI (20)
6.79
Neutral
Pivot points (classic, last session)
S3
4.05
S2
4.19
S1
4.47
Pivot
4.61
R1
4.89
R2
5.03
R3
5.31
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in BRL. Educational only, not financial advice.
